Johnson Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems

Food and Healthcare Press Releases Tuesday November 14, 2017 16:03
SAN FRANCISCO--14 Nov--PRNewswire/InfoQuest

Johnson & Johnson Innovation LLC, in collaboration with Johnson & Johnson Consumer Inc., today announced the launch of the Digital Beauty QuickFire Challenge. The challenge will encourage start-up companies to create the most novel, future-forward digital beauty solutions in an effort to provide better skincare outcomes for consumers around the world. The winner(s) of the challenge will receive up to a total of $50,000 in funding to help advance their product prototype toward commercialization. In addition to funding, Johnson & Johnson Innovation will also provide the winner(s) with access to a network of experts, residency for up to one year at an available Johnson & Johnson Innovation, JLABS (JLABS), and admission to a Johnson & Johnson Consumer Experience Center (CxC). At the CxC, the winner(s) will be able to custom design and execute one free research initiative.

Logo - http://mma.prnewswire.com/media/602394/Johnson_Johnson_Innovation_Logo.jpg

"True innovation doesn't just elevate product experiences and outcomes—it challenges the very definition of skin care itself," said Sebastien Guillon, President, Global Beauty, Johnson & Johnson Consumer Inc. "The next beauty tech disrupters are out there, and this Challenge will help us identify the most promising potential partners in the co-creation of meaningful, future-forward skin solutions."

The QuickFire Challenge, an initiative from JLABS—the no strings attached incubators—seeks to empower and enable groundbreaking science and health solutions by encouraging students, entrepreneurs, researchers, and start-up companies to apply. The Digital Beauty QuickFire Challenge will focus on three innovation areas:

1. Insights-Generating Tools that empower consumers to make better informed skincare choices, such as at-home skin assessments, coaching engines, and personalization tools to simplify product selection and build regimen.

2. Impact Tracking Devices and Adherence Solutions that help improve consumers' skin health management by monitoring skin-impacting factors such as pollution, UV, and skin biomarkers.
3. Digital Technologies or Devices that increase efficacy beyond traditional topical applications to progress skin health for consumers with hard to treat concerns such as acne, photoaging, and eczema.

"To achieve this, we are seeking innovative devices and digital technology solutions to make the invisible visible and tackle the toughest skincare challenges," said Naomi Furgiuele, Vice President, Global Face and Sun R&D, Johnson & Johnson Consumer Inc. "By creating powerful connected experiences with those outside of our company walls, we are able to build consumer preference, loyalty, and unique personalization."

Information about entering the challenge and entry guidelines can be found online at https://jlabs.tv/DigitalBeauty . The deadline to submit an application is January 19, 2018. Qualifying entries will be evaluated and the winner(s) will be selected and announced in Spring 2018.

About Johnson & Johnson Innovation

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com .

About Johnson & Johnson Innovation, JLABS

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. For more information about JLABS, please visit www.jlabs.jnjinnovation.com .

About Johnson & Johnson Consumer Inc.

Johnson & Johnson Consumer Inc. is one of the world's largest consumer health and personal care product companies. With its global headquarters located in New Brunswick, NJ, Johnson & Johnson Consumer Inc. produces many of the world's most trusted brands: JOHNSON'S(R), BAND-AID(R) Brand Adhesive Bandages, NEUTROGENA(R), TYLENOL(R), MOTRIN(R), and LISTERINE(R). Johnson & Johnson Consumer Inc. embraces innovative science to create products that anticipate consumer needs, while also creating experiences that help consumers live healthy, vibrant lives. For more information about Johnson & Johnson Consumer Inc., please visit https://www.jnj.com/healthcare-products/consumer .


Latest Press Release

APEC#s Rare Disease Action Plan Sets Precedent to Integrate Rare Disease Care by 2025

- Asia-Pacific Economic Cooperation (APEC) Life Sciences Innovation Forum (LSIF) Rare Disease Network comprises Rare Disease International, Queensland University of Technology and Shire (representing as industry co-chair). - Aims to define, diagnose and...

Grunenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US

Grunenthal announced today that it has acquired the US-based pharmaceutical company Averitas Pharma, thereby extending its commercial footprint to the United States. Averitas Pharma will be commercialising the pain patch Qutenza(R) (8 % capsaicin) for...

Ascensia Diabetes Care Highlights the Support That Families Provide for People With Diabetes To Mark World Diabetes Day 2018

Today, Ascensia Diabetes Care, a global leading diabetes care company, launched their campaign for World Diabetes Day 2018 to celebrate the important role of families for people with diabetes. They are publishing 38 online artworks that tell the stories...

Qatar Foundation Ushers in New Era of Healthcare With Official Inauguration of Sidra Medicine

Her Highness Sheikha Moza bint Nasser, Chairperson of Qatar Foundation (QF), today officially inaugurated Sidra Medicine - a brand new, world-leading women's and children's hospital in Qatar. The grand opening reflects the country's broader focus and...

Singapore National Eye Centre, Singapore Eye Research Institute And Johnson Johnson Vision Set Sights On Halting Global Myopia Epidemic

New US$26.35 Million Collaboration Seeks Prevention and Treatment Solutions to Address Rising Burden of Condition The Singapore National Eye Centre (SNEC), the Singapore Eye Research Institute (SERI) and Johnson & Johnson Vision today announced a...

Related Topics